India's Nos1 Weekly For The Pharmaceutical Industry
Home || About us || Feedback|| Advertising || Subscribe || Archives 

28th June 2001

Home > Top Stories

 

Indo-Polish biotech venture feared to come a cropper
S Harachand - Mumbai

THE bilateral agreement reached three months ago between the govts of India and Poland to explore the biotechnological approaches to herbal drug development is feared to come a cropper, thanks to the paucity of funds and byzantine bureaucratic delays.

The memorandum of understanding (MoU) signed by the two, at the beginning of this year, was actually part of a broader treaty for exchange of information that the Ministry of Science & Technology entered into with the Polish government, two years back. As per the MoU, both countries have embarked upon a project to identify and develop certain phyto molecules for a wide range of clinical indications.

There was also a consensus that the patents rights of lead candidates will be jointly held by India and Poland.

Consequently, experts from both the countries met at a symposium held at Jaipur, Rajasthan in March to work out the practical aspects. ‘‘The idea was basically to exploit the strengths of both. To make use of the best available expertise,’’ said a researcher from an Indian pharma company who also participated in the symposium.

The Indian expertise was primarily sought for identification of plant species and development utilising the CSIR facilities at various parts of the country. Likewise, the Polish scientists were expected to support with the technical know-how and industrial back up, where their actual strengths lie, he said. ‘‘They had also shortlisted three potential herbs: Withania Somnifera, Picrorhiza Kurroa and Berberis Arista for screening and further analysis,’’ he added.

The sad part of the story is that, despite all the initial euphoria, the whole programme did not go any further or has made little or nil progress. When contacted the Department of Biotechnology (DBT) sources said the proposal was still in a basic stage and details are yet to be evolved. ‘‘The department is still pursuing the project. There was also a proposal to set up a joint R&D lab,’’ said a DBT official.

However, sources which are close to S&T ministry say that this project also met with the inevitable and gathering dust. They point out two major impediments which hamper the project take-off. One is, fund crunch. Due to the current financial slump, the Polish govt is not in a position to cough up the fund to finance the project. Now Poland expects India to provide the funds. Secondly, they blame the Polish bureaucratic system for the inordinate delays.

In any case, perhaps with all its scope and potential, one more project is seemingly being buried without seeing the light of the day, mired in lethargy and official disinterest.

(With inputs from GI Gireesh Chandra Prasad/New Delhi)

<< Previous Story Next Story >>

Express Pharma Pulse
Research
World News
Technology Trends
Corporate Monitor
Scrip Scan
IT in Pharma
Policies & Amendments
Products & Processes
Pharma Allied
Bulk Drug Prices
Trade Winds
Edit
Events

<Top> Home || About us || Feedback|| Advertising || Subscribe || Archives 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.